Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04039074
Other study ID # Relax
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 29, 2019
Est. completion date June 30, 2021

Study information

Verified date September 2022
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to measure the effects of three stress reduction methods on patients with stress and stress associated complaints.


Recruitment information / eligibility

Status Completed
Enrollment 102
Est. completion date June 30, 2021
Est. primary completion date January 21, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - stress with at least 4 of 10 points on the Numeric Analogue Scale (NAS) at least 1 month and at least 3 of the following 8 stress symptoms: sleep disorder, inappetence or increased appetite, shoulder neck tension/back pain, tension headache, concentration disorder, exhaustion, nervousness/irritability, stress-associated digestive problems Exclusion Criteria: - serious acute or chronic diseases - pregnancy or lactation - known serious mental illness - immobility or restriction for gymnastics exercises due to orthopaedic, neurological or other medical cause - participation in another study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Integrative Yoga
A 12-week "Integrative Yoga" intervention which has meditative and psycho-educational components corresponding to traditional yoga practice.
Iyengar Yoga
A 12-week established, predominantly body-oriented yoga intervention (Iyengar yoga).
Mindfulness
A 12-week mindfulness intervention designed for the healthy handling of stress.

Locations

Country Name City State
Germany Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Qualitative interviews in focus groups interviews Qualitative assessment will be carried out in 45-minute focus group interviews in 12 (randomized selected) patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis. 12 weeks after inclusion
Primary Stress questionnaire (Cohen Perceived Stress Scale, CPSS) Change from Baseline in the CPSS, range from 0 to 4 in each item. Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the positively stated items and then summing across all scale items while higher values meaning a higher grade of perceived stress. Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Medical Outcomes Study Short Form Quality of Life (MOS SF-36) Assessing full scale, range 0-100, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Hospital Anxiety and Depression Scale (HADS) Assessing full scale, range 0-42, lower score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Zerssen symptom list (B-LR and B-LR') Assessing full scale, range 20-80, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary International Physical Activity Questionnaire (IPAQ) MET minutes represent the amount of energy expended carrying out physical activity. To get a continuous variable score from the IPAQ (MET minutes a week) we will consider walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS. Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Maslach Burnout Inventory (MBI) Assessing full scale, range 0-96, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Mindfulness (Freiburger Fragebogen zur Achtsamkeit, FFA) Assessing full scale, range 0-56, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Aspects of Spirituality (ASP) Assessing full scale, range 0-112, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Self-Regulation Assessing full scale, range 16-96, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Multidimensional Assessment of Interoceptive Awareness (MAIA) Assessing full scale, range 0-160, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Trauma symptoms (Posttraumatic Checklist, PCL-5) Assessing full scale, range 0-80, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Mysticism Scale Short Form Assessing full scale, range 0-32, higher score meaning a better outcome Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Numerical Analog Scales Assessing stress, back pain, headache, shoulder/neck tension, sleep quality, exhaustion, nervousness, digestive complaints, mood on 0-11 points each. Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Expectation questions For intervention 1, intervention 2 and intervention 3 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all) Date of inclusion (baseline)
Secondary Evaluation questions For intervention 1, intervention 2 and intervention 3 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all) After 12 weeks, after 24 weeks
Secondary Bio-electrical Impedance Analysis (BIA) Estimation of the body composition via bio-electrical impedance analysis (muscle mass in kg) Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Dietary Behaviour assessed by Food Frequency Questionaire (Gesundheit Erwachsener in Deutschland, DEGS) Quantitative description of nutritional habits Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Medication intake Name of medication and dosage Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Heart Rate Variability (HRV) 24h measuring by Faros 180 (chest) Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Sociodemographic Measurements Age, gender, education level, household income, employment status, marital status, language spoken, complete family history, current and previous illness and co-morbidities, and current medications Date of inclusion (baseline)
Secondary Behavioral questions: alcohol consumption Number of alcoholic beverages on average per week in the last month Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Behavioral questions: relaxation Relaxation behavior on average per week in the last month in minutes Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Behavioral questions: cigarettes Number of cigarettes on average per week in the last month in minutes Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Electrodermal Activity (Galvanic Skin Response) 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Blood Volume Pulse 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Respiration Rate 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Interbeat Interval (IBI) 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Heart Rate (HR) 24h measuring by Faros 180 (chest), Biovotion Everion Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Skin Temperature 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Blood Oxygenization 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Body weight (kg) 24h measuring by Biovotion Everion device Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Body Mass Index (kg/m2) Date of inclusion (baseline), after 12 weeks, after 24 weeks
Secondary Waist circumference (cm) Date of inclusion (baseline), after 12 weeks, after 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT04549194 - Contribution of L-Tyrosine to Recovery From Operational Strain on Return From External Operation N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Recruiting NCT05419934 - EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial N/A
Completed NCT03689348 - Acute and Chronic Effects of Avena Sativa on Cognition and Stress N/A
Active, not recruiting NCT05114824 - Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students N/A
Recruiting NCT05991739 - Pilot Testing of a Structural Racism Intervention for Immigrant Latinx Families N/A
Not yet recruiting NCT05491122 - The Influence of Fluid Intake on Daily Biological Rhythm and Mental Performance in Healthy Young Adults N/A
Completed NCT02982070 - TU Tough: Mental Toughness Training for College Success N/A
Completed NCT02844478 - Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging N/A
Completed NCT02417454 - Study on the Effects of a Probiotic on Autonomic and Psychological Stress Phase 3
Completed NCT06014970 - The Health and Wellness Curriculum Assessment N/A
Completed NCT01946893 - Mindfulness Meditation for Cognition and Mood N/A
Completed NCT01637363 - Psychoeducation to Sick-listed Individuals With Mental Health Problems N/A
Completed NCT01343810 - Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers N/A
Completed NCT00661271 - Mindfulness-based Stress Reduction for Urban Youth N/A
Recruiting NCT04417153 - Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
Completed NCT04125810 - A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress Phase 2
Completed NCT04023968 - Student Wellness Workshop Study N/A
Completed NCT03233750 - Simulation-Based Stress Inoculation Training N/A